Roberta Soscia
Rome, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Molecular measurable residual disease by immunoglobulin gene rearrangements on circulating tumor DNA predicts outcome in diffuse large B-cell lymphoma.
Journal: Haematologica
Published: July 24, 2024
Research Topic: Measurable Residual Disease in Hematologic Malignancies. Can digital droplet PCR improve measurable residual disease monitoring in chronic lymphoid malignancies?
Journal: Frontiers in oncology
Published: January 27, 2023
Optimizing Molecular Minimal Residual Disease Analysis in Adult Acute Lymphoblastic Leukemia.
Journal: Cancers
Published: December 12, 2022
Circulating cell-free DNA for target quantification in hematologic malignancies: Validation of a protocol to overcome pre-analytical biases.
Journal: Hematological oncology
Published: July 11, 2022
Digital Droplet PCR Is a Reliable Tool to Improve Minimal Residual Disease Stratification in Adult Philadelphia-Negative Acute Lymphoblastic Leukemia.
Journal: The Journal of molecular diagnostics : JMD
Published: November 23, 2021
Sialylation regulates migration in chronic lymphocytic leukemia.
Journal: Haematologica
Published: September 10, 2020
Immunoglobulin kappa deleting element rearrangements are candidate targets for minimal residual disease evaluation in mantle cell lymphoma.
Journal: Hematological oncology
Published: June 26, 2020
Treatment with ibrutinib does not induce a TP53 clonal evolution in chronic lymphocytic leukemia.
Journal: Haematologica
Published: June 18, 2020
Digital droplet PCR and next-generation sequencing refine minimal residual disease monitoring in acute lymphoblastic leukemia.
Journal: Leukemia & lymphoma
Published: May 04, 2019
Last Updated: 09/26/2026